Synapse - Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma

Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma Meeting Abstract

Authors:	Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; Matasar, M. J.; Mccall, S.; Moskowitz, A. J.; Noy, A.; Palomba, L.; Portlock, C. S.; Straus, D. J.; Verwys, S.; Zelenetz, A. D.; Zhang, Z. G.; Younes, A.; Moskowitz, C. H.
Abstract Title:	Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
Meeting Title:	56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	124
Issue:	21
Meeting Dates:	2014 Dec 6-9
Meeting Location:	San Francisco, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2014-12-06
Language:	English
ACCESSION:	WOS:000349243501070
PROVIDER:	wos
DOI:	10.1182/blood.V124.21.3085.3085
Notes:	Meeting Abstract: 3085 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos